Defensive patent strategies in the European pharmaceutical industry

dc.contributor.advisor	Mantrovs, Vadims
dc.contributor.author	Skļamina, Zane
dc.contributor.other	Riga Graduate School of Law	en
dc.date.accessioned	2020-01-22T12:29:31Z
dc.date.available	2020-01-22T12:29:31Z
dc.date.issued	2019
dc.identifier.uri	https://dspace.lu.lv/dspace/handle/7/49593
dc.description.abstract	For the purposes of keeping their commercial activities as effective and successful as possible, pharmaceutical companies can be eager to use different defensive strategies to protect their inventions and investments. Therefore, the main purpose of this master thesis is to examine certain defensive patent strategies used in the pharmaceutical industry, focusing on the European Union, and consequently establishing what are the problems and advantages related to these strategies.	en_US
dc.language.iso	eng	en_US
dc.publisher	Riga Graduate School of Law	en_US
dc.rights	info:eu-repo/semantics/restrictedAccess	en_US
dc.subject	Research Subject Categories::LAW/JURISPRUDENCE::Other law::European law	en_US
dc.subject	Pharmaceutical industry	en_US
dc.title	Defensive patent strategies in the European pharmaceutical industry	en_US
dc.type	info:eu-repo/semantics/masterThesis	en_US